{"bill": {"#text": "\n\t", "form": {"current-chamber": {"#tail": "\n\t\t", "#text": "IN THE HOUSE OF REPRESENTATIVES"}, "#text": "\n\t\t", "congress": {"#tail": "\n\t\t", "#text": "113th CONGRESS"}, "#tail": "\n\t", "legis-num": {"#tail": "\n\t\t", "#text": "H. R. 2148"}, "official-title": {"#tail": "\n\t", "#text": "To amend the Office of National Drug Control Policy\n\t\t  Reauthorization Act of 1998 to increase public awareness about the dangers of\n\t\t  synthetic drugs through the national youth antidrug media\n\t\t  campaign."}, "session": {"#tail": "\n\t\t", "#text": "1st Session"}, "distribution-code": {"#tail": "\n\t\t", "@display": "yes", "#text": "I"}, "action": {"action-date": {"#tail": "\n\t\t\t", "@date": "20130523", "#text": "May 23, 2013"}, "#tail": "\n\t\t", "action-desc": {"#tail": "\n\t\t", "#text": "\n        ", "sponsor": {"#tail": "\n\t\t\t introduced the following bill; which was referred to the\n\t\t\t ", "#text": "Mr. Carson of Indiana", "@name-id": "C001072"}, "committee-name": {"#tail": "\n      ", "@committee-id": "HIF00", "#text": "Committee on Energy and\n\t\t\t Commerce"}}, "#text": "\n\t\t\t"}, "legis-type": {"#tail": "\n\t\t", "#text": "A BILL"}}, "@bill-stage": "Introduced-in-House", "@bill-type": "olc", "@dms-id": "H5902804FF7B948C0882071E8543911FA", "@public-private": "public", "legis-body": {"#tail": "\n", "@style": "OLC", "section": [{"@section-type": "section-one", "#tail": "\n    ", "text": {"#tail": "\n\t\t", "quote": {"short-title": {"#tail": "\n        ", "#text": "Synthetics are Dangerous Act of\n\t\t\t 2013"}, "#tail": ".", "#text": "\n          "}, "#text": "This Act may be cited as the\n\t\t\t ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "1."}, "header": {"#tail": "\n      ", "#text": "Short title"}, "#text": "\n      ", "@id": "H7FE5DC9C838E418D92D73F6559AD6940"}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " finds as follows:", "@entity-type": "federal-body", "#text": "Congress", "@entity-id": "0001"}, "#text": "The ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "2."}, "header": {"#tail": "\n      ", "#text": "Findings"}, "paragraph": [{"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "#text": "Synthetic drugs,\n\t\t\t sometimes referred to as designer drugs, are chemical compounds produced in\n\t\t\t clandestine laboratories to mimic or enhance the effects of schedule I\n\t\t\t controlled substances such as methamphetamine, ecstasy, and marijuana."}, "enum": {"#tail": "\n        ", "#text": "(1)"}, "@id": "HD60D6C6A77984579A7BF83EE875AD6AB", "#text": "\n        "}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "#text": "Given the lack of\n\t\t\t extensive medical research on many synthetic drugs and their various analogues,\n\t\t\t the full scope of their harmful effects is not well understood."}, "enum": {"#tail": "\n        ", "#text": "(2)"}, "@id": "HCDD81A0529B14AF69F9058E653E7A242", "#text": "\n        "}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "quote": [{"#tail": " and ", "#text": "K2"}, {"#tail": ") and synthetic\n\t\t\t stimulants (such as ", "#text": "spice"}, {"#tail": ") are, nevertheless,\n\t\t\t alarming\u2014", "#text": "bath salts"}], "#text": "The circumstantial\n\t\t\t evidence of the harmful effects of synthetic drugs, particularly synthetic\n\t\t\t cannabinoids (such as "}, "enum": {"#tail": "\n        ", "#text": "(3)"}, "#text": "\n        ", "@id": "H2DD4ABE460E345B49D8710D93C99D0B4", "subparagraph": [{"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "#text": "in 2010, more than\n\t\t\t 11,000 individuals were admitted into the emergency room from complications\n\t\t\t arising from synthetic drug use, and nearly 25 percent of those patients\n\t\t\t required further medical treatment; and"}, "enum": {"#tail": "\n          ", "#text": "(A)"}, "@id": "H6949568A72D847E48397B25291A9C009", "#text": "\n          "}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "#text": "in 2011, the\n\t\t\t American Association of Poison Control Centers reported more than a two-fold\n\t\t\t increase in the number of calls related to synthetic marijuana from the\n\t\t\t previous year."}, "enum": {"#tail": "\n          ", "#text": "(B)"}, "@id": "H513E062DDAC34E4FB96D8C4747C056D4", "#text": "\n          "}]}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "#text": "The harmful\n\t\t\t effects of ingesting synthetic drugs include but are not limited to agitation,\n\t\t\t anxiety, nausea, vomiting, tachycardia, elevated blood pressure, tremor,\n\t\t\t seizures, hallucinations, paranoid behavior, and nonresponsiveness."}, "enum": {"#tail": "\n        ", "#text": "(4)"}, "@id": "H0777CB3AA7FD4D35B5F993FFAC146F8F", "#text": "\n        "}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "#text": "Like all schedule\n\t\t\t I drugs, these synthetic drugs are drugs that have a high potential for abuse,\n\t\t\t have no medical use in the United States, and lack an accepted safe use."}, "enum": {"#tail": "\n        ", "#text": "(5)"}, "@id": "HF22CAB7F6B2B465198CB99A2A66E15DF", "#text": "\n        "}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " was an important step in reducing\n\t\t\t the access of teens and young adults to dangerous and addictive synthetic\n\t\t\t drugs.", "@entity-type": "act", "#text": "Synthetic Drug Abuse Prevention Act of 2012", "@value": "Synthetic Drug Abuse Prevention Act of 2012"}, "#text": "The passage of the\n\t\t\t "}, "enum": {"#tail": "\n        ", "#text": "(6)"}, "@id": "HB3B44734B95E45C6B54C51A22C1BFC3D", "#text": "\n        "}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "#text": "New synthetic\n\t\t\t drugs are being manufactured that contain chemical compounds not found on\n\t\t\t schedule I, as set forth in ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": ", that nevertheless mimic or enhance the effects of controlled\n\t\t\t substances like methamphetamine, marijuana, ecstasy, and LSD.", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " (", "@entity-type": "act", "#text": "section 202(c) of the Controlled Substances Act", "@value": "Controlled Substances Act/s:202/ss:c"}, {"#tail": ")", "@entity-type": "uscode", "#text": "21\n\t\t\t U.S.C. 812(c)", "@value": "usc/21/812/c"}], "@entity-type": "law-citation", "#text": "\n            "}}, "enum": {"#tail": "\n        ", "#text": "(7)"}, "@id": "H572E4F19E87F4CF6A8BF2B91C8D330C7", "#text": "\n        "}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "#text": "Hundreds,\n\t\t\t potentially thousands, of teens and young adults will be admitted into\n\t\t\t emergency rooms around the country from complications caused by the ingestion\n\t\t\t of the next breed of harmful, synthetic drugs."}, "enum": {"#tail": "\n        ", "#text": "(8)"}, "@id": "H23361BD21F094B3CACE2B388E6F2DB67", "#text": "\n        "}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " that there is an urgent need, particularly among teens, young\n\t\t\t adults, and parents, to raise awareness about the dangers of these new\n\t\t\t synthetic drugs.", "@entity-type": "federal-body", "#text": "Congress", "@entity-id": "0001"}, "#text": "It is the sense of\n\t\t\t the "}, "enum": {"#tail": "\n        ", "#text": "(9)"}, "@id": "HC1B5CE3367894D1483ABF687C1D4A353", "#text": "\n        "}], "#text": "\n      ", "@id": "H46F538E607C14239BF89B36AC4B1FAA8"}, {"#tail": "\n  ", "text": {"#tail": "\n\t\t\t", "#text": "\n        ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended\u2014", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " (", "@entity-type": "act", "#text": "Section 709 of the\n\t\t\t Office of National Drug Control Policy Reauthorization Act of 1998", "@value": "Office of National Drug Control Policy Reauthorization Act of 1998/s:709"}, {"#tail": ")", "@entity-type": "uscode", "#text": "21 U.S.C.\n\t\t\t 1708", "@value": "usc/21/1708"}], "@entity-type": "law-citation", "#text": "\n          "}, "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "3."}, "header": {"#tail": "\n      ", "#text": "Increasing public\n\t\t\t awareness of dangers of synthetic drugs through national youth antidrug media\n\t\t\t campaign"}, "paragraph": [{"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", by inserting ", "@entity-type": "act", "#text": "subsection\n\t\t\t (a)(3)", "@value": "Office of National Drug Control Policy Reauthorization Act of 1998/s:709/ss:a/p:3"}, "#text": "in ", "quote": [{"#tail": " after ", "#text": "and synthetic drug use"}, {"#tail": "; and", "#text": "illegal\n\t\t\t drug use"}]}, "enum": {"#tail": "\n        ", "#text": "(1)"}, "@id": "HB7AFA00A59A4417395A1E4F693DE2C83", "#text": "\n        "}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " as ", "@entity-type": "act", "#text": "subsection (l)", "@value": "Office of National Drug Control Policy Reauthorization Act of 1998/s:709/ss:l"}, {"#tail": " and inserting after subsection (k) the\n\t\t\t following new subsection:", "@entity-type": "act", "#text": "subsection (m)", "@value": "Office of National Drug Control Policy Reauthorization Act of 1998/s:709/ss:m", "@proposed": "true"}], "#text": "by redesignating\n\t\t\t "}, "enum": {"#tail": "\n        ", "#text": "(2)"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n        ", "#text": "."}, "#tail": "\n\t\t\t", "subsection": {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "For\n\t\t\t\tpurposes of this section:"}, "enum": {"#tail": "\n            ", "#text": "(l)"}, "header": {"#tail": "\n            ", "#text": "Definitions"}, "paragraph": [{"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "quote": {"#tail": " has the meaning given such term in ", "#text": "drug"}, "#text": "The\n\t\t\t\tterm ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " and\n\t\t\t\tincludes a synthetic drug.", "@entity-type": "act", "#text": "section 702(3)", "@value": "Office of National Drug Control Policy Reauthorization Act of 1998/s:702/p:3"}}, "enum": {"#tail": "\n              ", "#text": "(1)"}, "header": {"#tail": "\n              ", "#text": "Drug"}, "#text": "\n              ", "@id": "H1C78056CC190441FB248DABC90D4286F"}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t", "quote": {"#tail": " means an artificially\n\t\t\t\tproduced substance that, as determined by the ", "#text": "synthetic drug"}, "#text": "The term ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": ", but is not itself a controlled\n\t\t\t\tsubstance.", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "section 102(6) of the\n\t\t\t\tControlled Substances Act", "@value": "Controlled Substances Act/s:102/p:6"}, "@entity-type": "law-citation", "#text": "\n                  ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                  ", "@entity-type": "uscode", "#text": "21 U.S.C. 802(6)", "@value": "usc/21/802//6"}, "@parsable-cite": "usc/21/802", "#text": "\n                    ", "@legal-doc": "usc"}}, "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", is an analog or\n\t\t\t\tderivative of a controlled substance (as defined in ", "@entity-type": "federal-body", "#text": "Director", "@entity-id": "1127"}}, "enum": {"#tail": "\n              ", "#text": "(2)"}, "header": {"#tail": "\n              ", "#text": "Synthetic\n\t\t\t\tdrug"}, "#text": "\n              ", "@id": "HD4145B1D96154FF3B2C519B65FF0BD62"}], "#text": "\n            ", "@id": "H19F2D9F29CD94B308CCAB5815E085F0E"}, "#text": "\n\t\t\t\t\t", "@id": "H4BBB8A8379864E069B08BC3943970BDB"}, "#text": "\n        ", "@id": "HC140AFCA6EB34DA9A2CC16D1710DD432"}], "#text": "\n      ", "@id": "HBB8C0E79740F499394DEC98937906F15"}], "#text": "\n\t\t", "@id": "H3993B9285B11413FB34772DDE6447A76"}, "metadata": {"#tail": "\n", "dublinCore": {"{http://purl.org/dc/elements/1.1/}date": {"#tail": "\n", "#text": "2013-05-23"}, "{http://purl.org/dc/elements/1.1/}format": {"#tail": "\n", "#text": "text/xml"}, "{http://purl.org/dc/elements/1.1/}language": {"#tail": "\n", "#text": "EN"}, "#tail": "\n", "{http://purl.org/dc/elements/1.1/}title": {"#tail": "\n", "#text": "113 HR 2148 IH: Synthetics are Dangerous Act of 2013"}, "{http://purl.org/dc/elements/1.1/}rights": {"#tail": "\n", "#text": "Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain."}, "{http://purl.org/dc/elements/1.1/}publisher": {"#tail": "\n", "#text": "U.S. House of Representatives"}, "#text": "\n"}, "#text": "\n"}}}